Chemotherapy dose-escalation with hemopoietic growth factor support in ovarian cancer.
Willemse
P H
PH
Department of Medical Oncology, University Hospital Groningen, The Netherlands.
Boonstra
H
H
de Vries
E G
EG
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000188:drug therapy; D016026:Bone Marrow Transplantation; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D007377:Interleukin-3 / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000628:therapy
D003115:Colony-Stimulating Factors; D007377:Interleukin-3; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor